Cholangiocarcinoma synonyms

Cholangiocarcinoma, commonly referred to as bile duct cancer, is a malignancy arising from the epithelial cells of the bile ducts. While the official medical term is cholangiocarcinoma, you may encounter it in older or specialized literature as bile duct carcinoma, biliary tract cancer, or perihilar cholangiocarcinoma, depending on the tumor's specific anatomical location.

What are the common names and synonyms for Cholangiocarcinoma?

In medical records, cholangiocarcinoma is frequently categorized by its location within the biliary tree. Because this cancer can develop anywhere along the bile ducts, clinicians often use specific terminology to describe the site of the disease. Understanding these variations is essential for patients navigating their diagnosis.

• Bile duct cancer: The most common layperson term.


• Biliary tract cancer: A broader category that sometimes includes gallbladder cancer.


• Klatskin tumor: A specific, historical name for a tumor located at the junction of the right and left hepatic ducts (perihilar cholangiocarcinoma).


• Intrahepatic, perihilar, or distal cholangiocarcinoma: Terms used to denote the exact anatomical origin, which significantly impacts treatment planning.

Why does Cholangiocarcinoma have multiple names?

The naming of cholangiocarcinoma has evolved due to advancements in diagnostic imaging and surgical classification. Historically, tumors in the biliary system were grouped together, but modern oncology distinguishes between intrahepatic and extrahepatic cholangiocarcinoma because they have different biological behaviors and clinical management protocols. Using precise anatomical terminology allows medical teams to define the scope of surgery or radiation therapy more effectively.

How is Cholangiocarcinoma classified in medical systems?

Official medical coding ensures consistent tracking of the disease across global health systems. In the ICD-10 and ICD-11, cholangiocarcinoma is classified under neoplasms of the biliary tract. Orphanet (ORPHA:182068) serves as a vital resource for rare disease classification, helping researchers and patients identify cholangiocarcinoma across international databases. Consistent nomenclature is critical for patients, especially when seeking second opinions or participating in clinical trials.

Next steps

• Consult a hepatobiliary surgeon or a medical oncologist specializing in gastrointestinal cancers.


• Request a copy of your pathology report to confirm the exact classification of your cholangiocarcinoma.


• Join the DiseaseMaps.org community to connect with others currently navigating a cholangiocarcinoma diagnosis.


• Visit the Cholangiocarcinoma Foundation for patient-specific resources and clinical trial matching.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare professional regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cholangiocarcinoma


• Orphanet: Rare disease database, ORPHA:182068


• National Cancer Institute (NCI): Biliary Tract Cancer information


• Cholangiocarcinoma Foundation: Comprehensive patient resource center